ePROM Monitoring of Patients With Inflammatory Arthritides May Be Beneficial, Review Suggests
July 15th 2023Utilizing electronic patient-reported outcome measures (ePROMs) may hold potential to reduce health care resource utilization without affecting outcomes for patients with inflammatory arthritides, such as rheumatoid arthritis.
Read More
Pembrolizumab Sustains Efficacy at 5 Years in First-Line, PD-L1+, Advanced NSCLC
July 15th 2023Findings from the 5-year follow-up analysis of the phase 3 KEYNOTE-042 study continue to support frontline pembrolizumab as standard of care for PD-L1-positive, locally advanced/metastatic non–small cell lung cancer (NSCLC).
Read More
Study Explores Risk Factors for Therapy-Related MDS, AML Following HCT for Multiple Myeloma
July 14th 2023The occurrence of treatment-related myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) after autologous hematopoietic cell transplantation (HCT) for multiple myeloma was associated with aggressive disease characteristics and poor outcomes.
Read More
Simple Screening Tool Might Help Detect Cognitive Deficits in Patients With pID
July 14th 2023Poor sleep quality might cause cognitive difficulties, while REM sleep might be protective against these difficulties, highlighting the usefulness of a simple neurocognitive screening tool for patients with persistent insomnia disorder (pID).
Read More
Texas Oncology's Sydney Townsend Spotlights Mental Health in Cancer Care Journey
July 14th 2023Sydney Townsend, executive director of digital health at Texas Oncology, explains how cancer diagnosis and treatment can impact a patient’s mental well-being and how she assesses a patient’s overall cancer care experience.
Watch
GERD Treatment May Yield More Favorable PH Outcomes for Patients With Codiagnoses
July 14th 2023This retrospective study shows that among nearly 160,000 patients with pulmonary hypertension (PH), those who also had gastroesophageal reflux disease (GERD) had lower rates of morbidity and mortality.
Read More
What We’re Reading: New CMS Proposals; WHO's Aspartame Warning; Reasonable COVID-19 Vaccine Prices
July 14th 2023CMS releases its 2024 Physician Fee Schedule, including a conversion factor cut, and proposes behavioral health efforts; a World Health Organization (WHO) agency says that aspartame may cause cancer, but another one maintains that it remains generally safe; HHS calls for COVID-19 vaccine manufacturers to ensure reasonable pricing for their upcoming fall shots.
Read More
Olaparib Increases Radioligand Activity in mCRPC, Early Findings Suggest
July 14th 2023Enhanced antitumor activity was seen with the addition of the PARP inhibitor olaparib to the radioligand lutetium Lu 177 vipivotide tetraxetan in patients with metastatic castration-resistant prostate cancer.
Read More
Limited Data Available on HPV Vaccine Immunogenicity, Efficacy in People Living With HIV
July 13th 2023Researchers summarized the limited available data on human papillomavirus (HPV) vaccine efficiency and immunogenicity in people living with HIV and gave insight into topics for further research.
Read More
Certain Gut Bacteria May Promote Disease Activity in Patients With Lupus Nephritis
July 13th 2023A study suggests that strains of ruminococcus (blautia) gnavus (RG) seen in the gut microbiome of patients in active lupus nephritis might be drivers of disease flares and highlight the possible pathogenic qualities of specific strains.
Read More
The FDA has approved the first over the counter (OTC) birth control pill Thursday; the US Chamber of Commerce has filed a motion for preliminary injunction on the Medicare Drug Price Negotiation program; individuals living in historically redlined areas are likely to have worse heart health.
Read More